PhotoCure ASA (LTS:0IMT)
kr 48.95 -0.35 (-0.71%) Market Cap: 1.34 Bil Enterprise Value: 1.05 Bil PE Ratio: 88.47 PB Ratio: 2.50 GF Score: 79/100

Q4 2019 Photocure ASA Earnings Call Transcript

Feb 27, 2020 / 07:30AM GMT
Release Date Price: kr75.6 (-14.19%)
Daniel Schneider
Photocure ASA - President & CEO

All right? All right. Good morning. Good morning, everyone. Welcome to Photocure's end of the year 2019 and Q4 presentation. I'm Dan Schneider, President and CEO. With me today is Erik Dahl, CFO. And I press the button. Usual disclaimers are in place for today's presentation.

So quick highlights on 2019. We continued positive growth rates in all regions of the world, Nordics, U.S. and our partner countries. As I mentioned last year, we put pressure on our partners in Europe, Ipsen, and they have responded in some of their countries, particularly Germany. We've had extremely strong revenue growth in the U.S. with fiscal year increase of 43%. It now represents about 50% of our total sales. If you remember, beginning 2018, it represented around 30%. So as this region of the world's business continues to grow, it have a greater impact on the total business of Photocure.

Our installed base of rigid and flex blue light cystoscopies is now 223. That was an increase of 66 scopes, 26 of them flexible scopes used in the surveillance market,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot